A federal judge has ruled on a discovery dispute involving patent infringement allegations, requiring an Italian company to make its accused product available for physical inspection.

Radius Health sued Orbicular Pharmaceutical and three related entities, asserting that an Abbreviated New Drug Application ("ANDA") for a generic version of Tymlos® infringed its U.S. 11,977,067 patent.

InMode accused BTL of infringing a patent related to vaginal remodeling technology and methods. Following a stay pending a decision on the institution of an inter partes review...

Nextcea accused Lipotype of inducing and contributing to infringement of method claims concerning testing for isomers indicative of phospholipidosis and other lysosomal storage disorders.

Plaintiff Amy Ruocco, acting pro se, accused Sandra Deveau, Sara Hazel, and Xavier Group KW Coastal & Lakes and Mountains of infringing Ruocco’s copyright in photographs...

Swissdigital had accused Samsonite of directly and indirectly infringing four patents – one covering luggage with a USB charging connector and three covering sheaths that can be incorporated into wearables or bags/luggage that provide for charging of personal devices.

On October 8, 2025, the United States Patent and Trademark Office (USPTO) announced the launch of its Artificial Intelligence Search Automated Pilot (ASAP!) Program.

Hybir accused Veeam of infringing patents relating to on-line backup systems that minimize duplication of the backed-up data at the source of the data. Judge Talwani found the asserted claims invalid...

A jury found that Abiomed's Impella intravascular pumps did not infringe Maquet's patent under the reverse doctrine of equivalents, despite meeting literal claim limitations, and determined the asserted patent claim was invalid for failing written description and enablement requirements. The case now awaits a judicial determination on whether assignor estoppel should preclude Abiomed from challenging the patent's validity.

In July 2025, Cogmedia accused Meta of patent infringement, and while not disputing that venue was proper in Massachusetts, Meta moved to transfer the case to the Northern District of California.

Maquet accused Abiomed of patent infringement involving intravascular blood pumps with steerable cannulas. The case centers on whether a patent claiming a blood pump genus is invalid for failing to describe internal motor species when only external motors were disclosed in the specification. Judge Saylor's ruling on summary judgment motions reveals critical questions about written description requirements and what constitutes claimed versus unclaimed elements in patent disputes.

On October 24, 2025 the United States Patent and Trademark Office (USPTO) announced the launch of a new pilot program that will afford patent Applicants...

On September 5, 2025, the Federal Trade Commission ("FTC") ended its quest to enact a nationwide ban of non-compete agreements. Specifically, the FTC voted to dismiss its appeal...

The U.S. Patent and Trademark Office (USPTO) recently issued new examination guidance that significantly relaxes the requirements for obtaining design patents covering digital interfaces, icons, and other computer-generated designs.

Rockefeller Photos sells photographs to food and beverage businesses throughout the country. It had licenses, which included exclusivity in certain areas, to photographs from Prepared Food Photos...

MSTM and co-plaintiff M&M Mass Spec Consulting, LLC alleged that Sciex entered into confidentiality and non-disclosure agreements in connection with considering taking a license on the plaintiffs' mass spectrometry...

In Ex parte Desjardins (Google's DeepMind Technologies), the USPTO's Appeals Review Panel (ARP) vacated a §101 rejection of claims directed to a machine-learning training method...

A professional photographer sued Iron Builders for copyright infringement after discovering his photograph on their business website. When Iron Builders failed to timely respond to a summary judgment motion, the court examined whether technical issues with electronic filing notices and alleged surprise constituted good cause for the delay.

Hikma manufactured generic icosapent ethyl, a drug pioneered by Amarin under the name Vascepa and approved by the FDA for the limited purpose of treating very high blood triglyceride levels, or severe...

Photographer David Gordon Oppenheimer accused DCB and Associates ("DCB") (a Century 21 business) and DCB's manager and another employee of infringing his copyright in an aerial picture of Boston...